Stepped care to improve PrEP use for pregnant and breastfeeding women in South Africa

Stepped care to optimize PrEP effectiveness in pregnant and postpartum women (SCOPE-PP) in South Africa

NIH-funded research University of California Los Angeles · NIH-11459364

This project offers a stepped approach to help pregnant and breastfeeding women in South Africa start and keep using HIV prevention medicine (PrEP).

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles NIH-funded
Lab location1 site (Los Angeles, United States)
Project IDNIH-11459364 on NIH RePORTER

What this research studies

You would be offered PrEP as part of routine antenatal and postnatal care and could receive extra supports that increase in intensity if you need them. Supports include counseling, HIV self-test kits for you and your partner(s), and enhanced adherence help for people struggling to stay on PrEP. Participants are placed into groups by chance so the team can compare which package helps more women stay protected through pregnancy and breastfeeding. The researchers will also look at costs and safety to advise national health policy and build on earlier local programs that integrated PrEP into prenatal clinics.

Who could benefit from this research

Good fit: Pregnant or breastfeeding women in South Africa who are HIV-negative and at risk for HIV infection, and who attend participating antenatal/postnatal clinics, are the intended participants.

Not a fit: People who are already living with HIV, not pregnant or breastfeeding, or not receiving care at participating clinics would not be eligible or likely to benefit from this PrEP-focused program.

Why it matters

Potential benefit: If successful, this approach could help more pregnant and postpartum women avoid HIV infection and cut the number of infant HIV cases by improving PrEP uptake and continuation.

How similar studies have performed: Previous research shows PrEP is safe and can prevent HIV in pregnancy and breastfeeding and earlier local work found integrated PrEP delivery acceptable, but keeping women on PrEP after delivery has proven difficult.

Where this research is happening

Los Angeles, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.